Navigation Links
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
Date:5/1/2012

SAN DIEGO, May 1, 2012 /PRNewswire/ -- Pfenex Inc. today announced that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised its option associated with the existing Pfenex contractual relationship begun in July, 2010. This extends the contract supporting the development of a robust Pfēnex Expression Technology™ based production strain and process for the production of bulk recombinant protective antigen (rPA) from anthrax. Pursuant to the contract, Pfenex will continue to develop an rPA-based anthrax vaccine from rPA produced in Pseudomonas fluorescens.  During the contract's base period, Pfenex demonstrated that a strongly immunogenic, stable and protective form of rPA could be expressed and recovered from the highly efficient fermentation of a strain of P. fluorescens engineered to produce rPA.

"We are pleased with the results and progress provided by Pfenex's recombinant platform technology to the production of a next generation anthrax vaccine," stated Bertrand C. Liang, Chief Executive Officer. "The exercise of this option by BARDA enables Pfenex and BARDA to continue our successful partnership sharing a common objective to develop an anthrax vaccine with a process capable of achieving the goals of the Strategic National Stockpile for the U.S. Government, including production, shelf life, and administration improvements."

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. OptiScan Biomedical Presents Study Results Demonstrating OptiScanners Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients
2. Biospace Lab and the Centre for Advanced Biomedical Imaging at University College London to Collaborate on Development of Novel Real-Time in Vivo Optical Imaging Technologies
3. What Recession? How Biomedical Device Companies Thrived in a Bad Economy
4. Crux Biomedicals IVC Filter Receives CE Mark Approval
5. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
6. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
7. Pepex Biomedical Signs Seven Year Deal to Manufacture "Trio™"
8. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
9. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
10. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
11. Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Companys Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... ... June 24, 2019 , ... ... is pleased to announce that its annual report, the 2018 Hospital Digital ... https://www.communicatorawards.com/winners/list/?event=1026&category=1915&award=8 in the Collateral category at the 25th Annual Communicator ...
(Date:6/20/2019)... ... June 20, 2019 , ... LuckyVitamin, an e-commerce specialty retailer ... Business Journal’s Healthiest Employers of 2019. LuckyVitamin’s Founder and Chief Wellness Spreader, Sam ... a ceremony at the Ballroom at the Ben on June 13, 2019. , ...
(Date:6/19/2019)... ... June 19, 2019 , ... Advocates for Physicians’ Rights (AFPR), ... and protection of physicians’ rights, asserts that the recent SB 276 Amendments encroach ... on narrow guidelines as a basis for issuing legitimate medical exemptions. , ...
Breaking Medicine Technology:
(Date:6/26/2019)... ... June 26, 2019 , ... CancerIQ , ... genetic counseling service, have integrated their technologies to better serve providers, health systems ... easily access or supplement genetic counseling resources for their institution to better identify ...
(Date:6/26/2019)... ... June 26, 2019 , ... ... worn-of-women brand female condom. , The VA is now available globally for consumer-direct ... VA breaks ground for female condom marketing with photographs displaying the new pink ...
(Date:6/25/2019)... CORALVILLE, Iowa (PRWEB) , ... June 25, 2019 ... ... company, announced today that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) ... point-of-care retinal imaging. This new code, submitted by the American Academy of ...
(Date:6/25/2019)... ... June 25, 2019 , ... The Global Smile Foundation will ... July thanks to 15-year-old Kylie Azizzadeh’s efforts fundraising for the mission. She has already ... before the mission takes place on July 15, 2019. , In 2018, Kylie ...
(Date:6/20/2019)... ... June 20, 2019 , ... Access ... services, announced that Angel Rosa has been appointed as Senior Vice President of ... and implementing new services, growing and nurturing high performing teams, and driving revenue ...
Breaking Medicine News(10 mins):